Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant M Schubert, F Bertoglio, S Steinke, PA Heine, MA Ynga-Durand, H Maass, ... BMC medicine 20 (1), 102, 2022 | 84 | 2022 |
Cytomegalovirus infection and inflammation in developing brain F Krstanović, WJ Britt, S Jonjić, I Brizić Viruses 13 (6), 1078, 2021 | 42 | 2021 |
Cannabinoids and hormone receptor-positive breast cancer treatment L Dobovišek, F Krstanović, S Borštnar, N Debeljak Cancers 12 (3), 525, 2020 | 40 | 2020 |
NK/ILC1 cells mediate neuroinflammation and brain pathology following congenital CMV infection D Kveštak, V Juranić Lisnić, B Lisnić, J Tomac, M Golemac, I Brizić, ... Journal of Experimental Medicine 218 (5), e20201503, 2021 | 26 | 2021 |
SARS-CoV-2 spike and nucleocapsid antibody response in vaccinated croatian healthcare workers and infected hospitalized patients: a single center cohort study PK Brlić, M Pavletić, M Lerga, F Krstanović, MP Matešić, K Miklić, S Malić, ... Viruses 14 (9), 1966, 2022 | 8 | 2022 |
SARS-CoV-2 viral load in the pulmonary compartment of critically ill COVID-19 patients correlates with viral serum load and fatal outcomes M Ynga-Durand, H Maaß, M Milošević, F Krstanović, M Pribanić Matešić, ... Viruses 14 (6), 1292, 2022 | 8 | 2022 |
Mouse models for cytomegalovirus infections in newborns and adults I Brizić, B Lisnić, F Krstanović, W Brune, H Hengel, S Jonjić Current protocols 2 (9), e537, 2022 | 5 | 2022 |
Fibroblasts are a site of murine cytomegalovirus lytic replication and Stat1-dependent latent persistence in vivo KM Sitnik, F Krstanović, N Gödecke, U Rand, T Kubsch, H Maaß, Y Kim, ... Nature Communications 14 (1), 3087, 2023 | 4 | 2023 |
Effect of combining CBD with standard breast cancer therapeutics L Dobovišek, M Novak, F Krstanović, S Borštnar, TL Turnšek, N Debeljak Advances in Cancer Biology-Metastasis 4, 100038, 2022 | 2 | 2022 |
Fibroblastic cells are a site of mouse cytomegalovirusin vivolytic replication and latent persistence oppositely regulated byStat1 KM Sitnik, F Krstanović, N Goedecke, U Rand, T Kubsch, H Maaß, Y Kim, ... | 1 | 2022 |
Neuro‐immune interactions in health and disease: Insights from FENS‐Hertie 2022 Winter School LB Binder, PB Rosa, BM de Sousa, LS Chagas, O Dubljević, ... European Journal of Neuroscience, 2024 | | 2024 |
Što je rak? P Kučan Brlić, V Juranić Lisnić, J Železnjak, M Mazor, ... Medicinski fakultet u Rijeci, 2023 | | 2023 |
Što rade znanstvenici? J Železnjak, M Mazor, P Kučan Brlić, V Juranić Lisnić, C Paulović, ... | | 2022 |
Što su protutijela? D Gašparini, P Kučan Brlić, V Juranić Lisnić, J Železnjak, M Mazor, ... | | 2022 |
Human serum from SARS-CoV-2 vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant (preprint) M Schubert, F Bertoglio, S Steinke, PA Heine, MA Ynga-Durand, F Zuo, ... | | 2021 |
Abstract P3-05-11: Cannabidiol increases potency of tamoxifen in inhibiting breast cancer cell viability L Dobovišek, M Novak, F Krstanović, P Ferk, S Borštnar, TL Turnšek, ... Cancer Research 80 (4_Supplement), P3-05-11-P3-05-11, 2020 | | 2020 |
Characterization of Cannabinoid Receptors in Breast Cancer Cell Lines: Master Thesis F Krstanović F. Krstanović, 2019 | | 2019 |
Characterization of cannabinoid receptors in breast cancer cell lines F Krstanović Univerza v Ljubljani, Fakulteta za kemijo in kemijsko tehnologijo, 2019 | | 2019 |
Phylogenomic Analysis of Pore Forming Toxins (PFT) in Eukaryotes: Diploma Thesis: University Study Programme Biochemistry-1st Cycle F Krstanović F. Krstanović, 2017 | | 2017 |